other material
confidence high
sentiment neutral
materiality 0.50
iBio closes public offering of common stock and warrants, raising ~$4.5M gross proceeds
iBio, Inc.
- Offering included 600K shares common stock, 1.65M pre-funded warrants, and 4.5M Series C/D warrants exercisable at $2.00.
- Gross proceeds of ~$4.5M; net proceeds for working capital, R&D, trial preparation, and severance payments.
- Placement agents A.G.P./Alliance Global Partners (lead) and Brookline Capital Markets receive 5.5% cash fee plus expense reimbursement.
- Tail warrants issued to H.C. Wainwright for 131,820 shares at $2.50 exercise price if certain investors participate.